Octreotide acetate

(Sandostatin lar)

Octreotide acetate

Drug updated on 10/23/2023

Dosage FormInjection (intramuscular: 10 mg/6 ml, 20 mg/6ml, 30 mg/6ml)
Drug ClassSomatostatin analogue
Ongoing and Completed StudiesClinicalTrials.gov

Indication

  • For acromegaly.
  • For severe diarrhea/flushing episodes associated with metastatic carcinoid tumors.
  • For profuse watery diarrhea associated with Vasoactive Intestinal Peptide (VIP) secreting tumors.